- ”Economic evaluation of immunoglobulin replacement in patients with primary antibody deficiencies”, J. Beauté, P. Lévy, V. Millet, M. Debré, Y. Dudoit, L. Le Mignot, N. Mahlaoui, A. Fischer, and the French PID study group, poster présenté au 13th Meeting of the European Society for Immunodeficiencies (ESID), ‘s-Hertogenbosch, The Netherlands, 16-19 octobre 2008.
- « Comparison of economic evaluation between three major HTA agencies. Is there a French touch? », Levy P, de Paz B, Guigand G et al., poster présenté au 18th Annual European Congress ISPOR, Milan, Italie, 7-11 nov 2015
- « Cost-effectiveness analyses in France, England and Canada: comparative analysis of structural choices, results and perspectives », Gregman C, Paubel P, Levy P, et al., poster présenté au 18th Annual European Congress ISPOR, Milan, Italie, 7-11 nov 2015
- « How to capture and reward the benefits associated with companion diagnostics? », Doutriaux A, Cognet M, Paubel P, Levy P; poster présenté au 18th Annual European Congress ISPOR, Milan, Italie, 7-11 nov 2015
- « How to model survival and QALYs in cost-effectiveness analysis? Differences between Markov and partitioned survival analysis models”, Minacori R, Bonastre J, Lueza B, Marguet S, Levy P; poster présenté au 18th Annual European Congress ISPOR, Milan, Italie, 7-11 nov 2015
- « Taking in account research and development expenditures to determine prices of medicines in France : a realistic alternative choice ? », poster n° PHP133 présenté au 19th Annual European Congress ISPOR, Vienna, Austria, 29 oct-2 nov 2016